Clincosm LogoSign in Get a demo

Malignant Melanoma

Showing NaN - NaN of 16
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumor, Castration-Resistant Prostatic Cancer, Malignant Melanoma Trial in United States (MGC018, lorigerlimab)

Recruiting
  • Advanced Solid Tumor
  • +6 more
  • vobramitamab duocarmazine
  • lorigerlimab
  • Los Angeles, California
  • +7 more
Jan 10, 2023

Advanced Solid Tumor, Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma Trial in United States (STK-012,

Recruiting
  • Advanced Solid Tumor
  • +10 more
  • Boston, Massachusetts
  • +8 more
Jan 2, 2023

Malignant Melanoma Trial in United States (BMS-936558 (MDX1106-04), Ipilimumab)

Completed
Has Results
  • Malignant Melanoma
  • New Haven, Connecticut
  • +3 more
Mar 19, 2021

Malignant Melanoma Trial in Worldwide (Placebo, Vemurafenib, Cobimetinib)

Completed
Has Results
  • Malignant Melanoma
  • Placebo
  • +2 more
  • Birmingham, Alabama
  • +155 more
Sep 14, 2020

Refractory Head Neck Cancer, Squamous Cell Carcinoma, Skin, Carcinoma of the Breast Trial in United States (HF10)

Completed
  • Refractory Head and Neck Cancer
  • +3 more
  • Bronx, New York
  • +4 more
May 21, 2019

Malignant Melanoma Trial in Pittsburgh (Decitabine, Temozolomide, biopsy)

Completed
Has Results
  • Malignant Melanoma
  • Pittsburgh, Pennsylvania
    UPMC Cancer Centers
Sep 5, 2017

Malignant Melanoma Trial in Worldwide (Ipilimumab)

Terminated
Has Results
  • Malignant Melanoma
  • Ipilimumab
  • Phoenix, Arizona
  • +31 more
Jul 31, 2017

Malignant Melanoma Trial in Australia, United States (vemurafenib)

Completed
Has Results
  • Malignant Melanoma
  • Los Angeles, California
  • +14 more
Jun 26, 2017

Malignant Melanoma Trial in United States (Vemurafenib)

Terminated
Has Results
  • Malignant Melanoma
  • Tucson, Arizona
  • +14 more
Apr 24, 2017

Malignant Melanoma Trial in Worldwide (Vemurafenib, Dacarbazine)

Completed
Has Results
  • Malignant Melanoma
  • Birmingham, Alabama
  • +110 more
Aug 19, 2016

Melanoma, Malignant Melanoma Trial in Israel, United States (CT-011)

Completed
  • Melanoma
  • Malignant Melanoma
  • New Haven, Connecticut
  • +17 more
Dec 16, 2015

Malignant Melanoma Trial in Norway, Sweden, United States (CP-4055, Sorafenib (Nexavar))

Completed
  • Malignant Melanoma
  • Pittsburgh, Pennsylvania
  • +5 more
Aug 28, 2013

Malignant Melanoma Trial in Worldwide (HSPPC-96 or Oncophage)

Completed
  • Malignant Melanoma
  • HSPPC-96 or Oncophage
  • Birmingham, Alabama
  • +76 more
Sep 6, 2012

Malignant Melanoma Trial in United States (CP-675,206)

Completed
  • Malignant Melanoma
  • Los Angeles, California
  • +8 more
Jun 5, 2012

Malignant Melanoma Trial in Pittsburgh (MEDI-522)

Completed
  • Malignant Melanoma
  • MEDI-522
  • Pittsburgh, Pennsylvania
    University Of Pittsburgh Cancer Institute
Mar 13, 2012

Malignant Melanoma, Tumor Metastasis Trial in Pittsburgh, Oslo, Lund (CP-4055 (ELACYT))

Completed
  • Malignant Melanoma
  • Neoplasm Metastasis
  • CP-4055 (ELACYT)
  • Pittsburgh, Pennsylvania
  • +2 more
Jul 9, 2007